About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Ohio | 172 Studies

Clinical Trials Brain CancerOhio

Brain Cancer Clinical Trials in Ohio

Find 172 clinical trials for brain cancer near Ohio. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 172 trials

Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRamucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: Monoclonal antibodies, such as ramucirumab and anti-PDGFR alpha monoclonal antibody IMC-3G3 (Olaratumab), can block tumor growth in different ways.NCT00895180·Birmingham, Alabama and 10 others

CompletedAcute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersRATIONALE: Learning about the side effects of stereotactic radiosurgery in patients with brain tumors or other brain disorders may help doctors plan treatment and help patients…NCT00255671·Cleveland, Ohio

CompletedDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaThis phase II trial studies how well dasatinib works in treating patients with glioblastoma multiforme or gliosarcoma that has come back.NCT00423735·Mobile, Alabama and 187 others

CompletedIL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaThis Phase 1 study in patients with newly diagnosed malignant glioma is designed to determine the highest dose of IL13-PE38QQR that can be safely administered by Convection…NCT00089427·San Francisco, California and 5 others

TerminatedTreatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to ChemotherapyCure rates for patients with high grade glioma remain disappointing, in part because tumor cells are often resistant to chemotherapy, and because using higher doses of…NCT00272870·Cincinnati, Ohio

CompletedPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaThis 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote…NCT01480479·Birmingham, Alabama and 222 others

TerminatedRadiosurgery Plus Bevacizumab in GlioblastomaRATIONALE: Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.NCT01086345·Cleveland, Ohio

RecruitingTargeted Pediatric High-Grade Glioma TherapyThe goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma.NCT05839379·Aurora, Colorado and 21 others

TerminatedDietary, Herbal and Alternative Medicine in Glioblastoma MultiformeRATIONALE: Giving the herb Boswellia serrata after surgery and radiation therapy may slow the growth of any remaining tumor cells.NCT00243022·Cleveland, Ohio

CompletedClinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaThis is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC).NCT03739372·San Diego, California and 11 others

CompletedAnti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)This phase I trial studies the safety and best dose of anti-LAG-3 (anti-LAG-3 monoclonal antibody BMS-986016) or urelumab alone and in combination with nivolumab in treating…NCT02658981·Birmingham, Alabama and 10 others

TerminatedTesting Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain TumorsRecent advances in technology have allowed for the detection of cell-free DNA (cfDNA). cfDNA is tumor DNA that can be found in the fluid that surrounds the brain and spinal cord…NCT05934630·Los Angeles, California and 9 others

WithdrawnMagnetic Resonance Fingerprinting Guided Extended Resection in GlioblastomasMagnetic resonance imaging, MRI, is a procedure that uses radio waves, a powerful magnet, and a computer to make a series of detailed pictures of areas inside the body.NCT06455189·Cleveland, Ohio

CompletedProcarbazine in Treating Patients With Recurrent Brain TumorRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004004·Birmingham, Alabama and 9 others

CompletedABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: ABT-888 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00770471·Birmingham, Alabama and 10 others

CompletedSafety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeThe purpose of this study is to determine the safety and efficacy of SL-701 as a treatment for recurrent glioblastoma multiform (GBM).NCT02078648·Birmingham, Alabama and 15 others

RecruitingBeginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareThis is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows: * A Screening/Baseline Period of 21 days.NCT07195591·Scottsdale, Arizona and 21 others

CompletedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or GliosarcomaThis randomized phase II trial is studying the side effects and how well giving bevacizumab together with irinotecan or temozolomide works in treating patients with recurrent or…NCT00433381·Mobile, Alabama and 92 others

CompletedBIBF 1120 for Recurrent High-Grade GliomasBIBF 1120 is a newly discovered compound that may stop cancer cells from growing abnormally.NCT01380782·Boston, Massachusetts and 3 others

PreviousPage 3 of 9Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia